Latest news & events
10th Anniversary of World MRSA Day
October 2nd 2018 will be the tenth anniversary of World MRSA Day
Colleagues and friends in America will kick off events on Saturday, September 29th 2018, with the tenth annual event of the MRSA and C.diff summit.
MRSA Survivors’ Network joined forces with MRSA Action UK on October 2nd 2008 to raise awareness of this global issue. Significant reductions in MRSA bloodstream infections have been seen in UK hospitals since the introduction of screening and other interventions to help keep patients safe from MRSA.
Screening is now carried out for higher risk patients in the UK and Jeanine Thomas has been campaigning ever since to bring this about across the USA.
C.diff (Clostridium difficile) remains an issue in UK and USA hospitals and in the community setting. With people living longer with more complex conditions, the high use of antibiotics can often bring about a change in gut flora which makes people more susceptible to the disease.
MRSA Survivors’ Network Event is being hosted in Hinsdale, Illinois from 10.30am to 12.30pm. The Master of Ceremony is Evening News Anchor for NBC5 Chicago Rob Stafford, free MRSA screening is being made available to the first 80 attendees and they will hear from Professor Michael S Pulia from the University of Wisconsin School of Medicine and Public Health.
World MRSA Day coincides with the Annual Infection Prevention Society Conference in Glasgow and MRSA Action UK will be encouraging members and delegates to mark the day by making pledges to say what they will be doing raise awareness and encourage good infection prevention and control.
Hand hygiene, good aseptic technique and appropriate prescribing of antibiotics remain the corner stones of prevention of infection in vulnerable patients.
More information about the event in the USA is available here
Have your say about what research is important and help keep research into healthcare associated infections in the spotlight
James Lind Alliance - Priority Setting Partnership (Healthcare associated infections)
Your opportunity to select the top ten priorities for research
Healthcare-associated infections (HCAI) are normally defined as infections that affect patients in a hospital or other healthcare facility, and are not present or incubating at the time of admission. They also include infections acquired by patients in the hospital or facility that appear after discharge, and occupational infections among healthcare professionals. HCAIs are the most frequent adverse event in healthcare delivery worldwide. HCAI is believed to cost the NHS at least £1bn annually and causes at least 5000 deaths every year. Many patients’ hospital stays are prolonged having a major impact on them and their families.
There are a number of different prevention, identification and treatment options for HCAI. It is important that we undertake research to try to understand which of these are effective and make a difference to those affected. Research should focus on questions that are important to people with, or at high risk of, HCAI, those who care for them and healthcare professionals who treat, identify and try to prevent infections. More....
Superbugs and the Role of Diagnostics - World Antibiotic Awareness Week
14 November 2017
The Longitude Prize and the Antimicrobial Research Centre at the London School of Hygiene and Tropical Medicine are holding an event to celebrate the third anniversary of the five year prize. ‘Superbugs and the Role of Diagnostics’ is being hosted on Tuesday 14 November, during World Antibiotic Awareness Week.
Dr Zoe Williams, resident doctor on This Morning and a presenter on BBC Two’s Trust Me I’m a Doctor, explores the lives of those affected by superbugs, the clinicians trying to help them and the teams coming up with solutions to reduce antibiotic resistance.
MRSA Action UK Vice Chair Helen Bronstein talks about her personal experience of MRSA having lost her mum to the superbug.
World Antibiotic Awareness Week
13 November 2017
Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. When the microorganisms become resistant to most antimicrobials they are often referred to as “superbugs”. This is a major concern because a resistant infection may kill, can spread to others, and imposes huge costs to individuals and society. Antimicrobial resistance threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. It is an increasingly serious threat to global public health that requires action across all government sectors and society.
Derek Butler was a founding member of MRSA Action UK following the loss of his stepfather to MRSA in 2003. This was not the first time he had lost a family member to this organism, his grandfather and uncle also succumbed to MRSA and died.
Derek and his partner Maria Cann worked with Manchester Science Partnerships on a short film recounting their personal experiences with MRSA and the Gram Negative bacteria Pseudomonas aeruginosa.
They are passionate about raising awareness and the need to tackle antimicrobial resistance, as these films demonstrate. More...
Conference with European Parliament, Brussels Scientific, Human Health, Husbandry, and Socio-Economic Aspects of Antimicrobial Resistance: Time to Act
28 June 2017
Susan Fallon-Knapper, Vice Chair MRSA Action UK told her moving story to MEPs in the European Parliament. It took courage to speak of events that led to her beautiful daughter Sammie passing away with MRSA at the young age of 17.
The conference was hosted by MEPs Ms. Adina-Iona Valean, Chair and Mr. Pavel Poc, Vice Chair of the Committee on the Environment, Public Health and Food Safety, and Mr. Fredrick Federley Committee on the Environment, Public Health and Food Safety and Committee on Agriculture and Rural Development.
Sue's presentation opened the event preceding Dr Marc Sprenger, Director of the AMR Secretariat of the World Health Organisation, who gave a Keynote speech on the theme of the UK’s All-Party Parliamentary Group on Patient Safety Report "Time to Act", published December 9th 2016.
Speaking at the event, Susan told how her daughter Samantha had died from Meticillin-resistant Staphylococcus aureus (MRSA), an infection caused by a type of bacteria that has become resistant to many of the antibiotics used to treat ordinary infections.
She gave a moving and emotional testimony on how 17-year-old Samantha never left hospital after being admitted for a relatively minor virus. Over the following four days, the college student suffered major organ failure and it was discovered she had MRSA in her nose, neck and lung. Sue spoke of how her personal tragedy highlighted the growing threat from antimicrobial resistance (AMR).
She was one of the keynote speakers at the half day conference, co-organised by PA International Foundation, which brought together MEPs, physicians and experts in the field.
Sue said "I want to call on the Parliament, on behalf of MRSA Action UK and all those who we support, to put in place rules and regulations to prevent people falling victim to AMR.
"We would like the Parliament to take the lead to ensure we protect our present stock of antibiotics and to help develop other antimicrobials for future generations.
"We are the golden generation who have been born and live in an antibiotic era, who have enjoyed the greatest leap in medical science in mankind.
"But I am asking for you to take the action required so that no one else has to go through what my family and I have been through." The event, which came on the eve of the Commission's new action plan on AMR, heard that bacteria found in humans, animals and food continue to show resistance to widely used antimicrobials.